Editorial board

Anti-infectives

Arturo Casadevall: Albert Einstein College of Medicine, USA
Erik De Clercq: Rega Institute for Medical Research, Belgium
Jack Sobel: Wayne State University School of Medicine, USA

Anti-inflammatory

Cezmi A Akdis: Swiss Institute of Allergy and Asthma Research, Switzerland
Paul Emery: University of Leeds, UK
Daniel E Levy: DEL BioPharma, USA
Fred Poordad: Texas Liver Institute and University of Texas Health San Antonio, San Antonio, TX, USA
Yoshiya Tanaka: University of Occupational and Environmental Health, Japan

Cardiovascular & Renal

Gregory Y. H. Lip: Chair of Cardiovascular Medicine, University of Liverpool, UK
Daniel E Levy: DEL BioPharma, USA
Giuseppe Mancia: University of Milano-Bicocca, Milan, Italy
Ron Waksman: Washington Hospital Center, USA
Alberico L Catapano: University of Milan, Italy

Central & Peripheral Nervous Systems

Philip N Patsalos: The National Hospital for Neurology & Neurosurgery, UK
Michael Berk: IMPACT Institute, Deakin University, Australia

Oncologic, Endocrine & Metabolic

Farhad Ravandi-Kashani: MD Anderson Cancer Center, USA
Frank J Giles: Northwestern Medicine Developmental Therapeutics Institute, USA
Cesare Gridelli: Moscati Hospital, Avellino, Italy
Gordon Lynch: University of Melbourne, Australia
Daniele Santini: University Campus Biomedico, Italy
Bruno Vincenzi: Campus Bio-Medico University, Italy

Pulmonary-Allergy, Dermatology, Gastrointestinal & Arthritis

Peter J Barnes: National Heart and Lung Institute, UK
Paul Emery: University of Leeds, UK
Paul Martin: University of Miami, USA